Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
4.17%
↓ 78% below average
Average (34q)
18.64%
Historical baseline
Range
High:1213.79%
Low:-380.81%
Volatility
8553.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 4.17% |
| Q2 2025 | 100.00% |
| Q1 2025 | 200.00% |
| Q4 2024 | 33.33% |
| Q3 2024 | -227.27% |
| Q2 2024 | 78.00% |
| Q1 2024 | -169.44% |
| Q4 2023 | 280.00% |
| Q3 2023 | -195.24% |
| Q2 2023 | 216.67% |
| Q1 2023 | -380.81% |
| Q4 2022 | -98.02% |
| Q3 2022 | 1213.79% |
| Q2 2022 | 19.44% |
| Q1 2022 | 32.08% |
| Q4 2021 | -20.45% |
| Q3 2021 | 27.87% |
| Q2 2021 | 15.28% |
| Q1 2021 | 8.86% |
| Q4 2020 | -19.70% |
| Q3 2020 | -1.54% |
| Q2 2020 | -35.42% |
| Q1 2020 | 17.24% |
| Q4 2019 | -18.37% |
| Q3 2019 | 27.94% |
| Q2 2019 | 46.46% |
| Q1 2019 | -44.32% |
| Q4 2018 | -72.55% |
| Q3 2018 | 54.05% |
| Q2 2018 | -226.47% |
| Q1 2018 | 66.34% |
| Q4 2017 | -106.12% |
| Q3 2017 | -40.00% |
| Q2 2017 | -133.33% |
| Q1 2017 | 0.00% |